Stockscreener 앱 받기
15.32
3.23%
0.48
시간 외 거래:
14.85
-0.47
-3.07%
전일 마감가:
$14.84
열려 있는:
$14.82
하루 거래량:
218.21K
Relative Volume:
1.17
시가총액:
$1.17B
수익:
-
순이익/손실:
$-46.13M
주가수익비율:
-18.86
EPS:
-0.8123
순현금흐름:
$-34.10M
1주 성능:
+0.07%
1개월 성능:
-9.24%
6개월 성능:
-13.88%
1년 성능:
+34.27%
1일 변동 폭
$14.68
$15.42
1주일 범위
$14.68
$15.42
52주 변동 폭
$11.13
$25.00
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
PLSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
15.32 | 1.17B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
540.60 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.27 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.30 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
255.88 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
221.22 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
Insider Sell: Darrin Uecker Sells 30,000 Shares of Pulse Bioscie - GuruFocus
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Nuveen Asset Management LLC Has $990,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
BNP Paribas Financial Markets Has $35,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Deutsche Bank AG Boosts Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 23, 2025 - BioSpace
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listi - GuruFocus
Bank of America Corp DE Has $13.73 Million Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership - Yahoo Finance
(PLSE) Proactive Strategies - news.stocktradersdaily.com
Tower Research Capital LLC TRC Has $29,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Transcript : Pulse Biosciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 05 - marketscreener.com
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call Transcript - Insider Monkey
Pulse Biosciences Earnings Call: Progress and Challenges - TipRanks
Barclays PLC Raises Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Reports Q1 2025 Financial Results - TipRanks
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Wells Fargo & Company MN Purchases 2,416 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Decoding Pulse Biosciences Inc (PLSE): A Strategic SWOT Insight - GuruFocus
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results - BioSpace
Earnings Flash (PLSE) Pulse Biosciences Q1 Loss $0.25 Vs. $0.18 Loss Year Ago - marketscreener.com
Earnings call transcript: Pulse Biosciences reports Q1 2025 loss, stock edges up - Investing.com
PULSE BIOSCIENCES, INC. SEC 10-Q Report - TradingView
Pulse Biosciences Inc Reports Q1 2025 Financial Results: GAAP Net Loss of $16.8 Million, Cash Reserves at $119.3 Million - GuruFocus
Concerns Raised Over Pulse Biosciences' (PLSE) Nano-Pulse Techno - GuruFocus
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference - Business Wire
Pulse Biosciences (PLSE) Faces Criticism Over Technology's Past Performance | PLSE Stock News - GuruFocus
PLSE Faces Skepticism over Nano-Pulse Stimulation's Commercial V - GuruFocus
Concerns Raised Over Pulse Biosciences' (PLSE) Nano-Pulse Technology | PLSE Stock News - GuruFocus
After the recent decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's holdings have lost 4.2% of their value - simplywall.st
Pulse Biosciences names Jon Skinner as new CFO - MSN
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting - Stock Titan
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by Legal & General Group Plc - Defense World
Head to Head Survey: Pulse Biosciences (NASDAQ:PLSE) & Sight Sciences (NASDAQ:SGHT) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Invesco Ltd. - Defense World
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 - BioSpace
Geode Capital Management LLC Increases Stock Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 | PLSE Stock News - GuruFocus
Pulse Biosciences (NASDAQ:PLSE) Is In A Strong Position To Grow Its Business - Yahoo Finance
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting - The Joplin Globe
Revolutionary Nanosecond PFA Heart Treatment Takes Center Stage at HRS 2025: J&J Partnership Revealed - Stock Titan
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
펄스 바이오 주식 (PLSE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| UECKER DARRIN | Chief Technology Officer |
Jun 13 '25 |
Sale |
15.98 |
15,000 |
239,700 |
122,872 |
0.46%
0.05%
자본화:
|
볼륨(24시간):